共 154 条
- [1] Loomba R(2013)The global NAFLD epidemic Nat Rev Gastroenterol Hepatol 10 686-690
- [2] Sanyal AJ(2017)Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies J Diabetes Metab Disord 16 21-1840
- [3] Shafiee G(2020)Health consequences of sarcopenic obesity: a narrative review Front Endocrinol (Lausanne) 11 332-1778
- [4] Keshtkar A(2021)Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United States Liver Int 41 1832-493
- [5] Soltani A(2014)Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study Hepatology 59 1772-1768
- [6] Ahadi Z(2015)Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008–2011) J Hepatol 63 486-76
- [7] Larijani B(2018)Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a 7-year longitudinal study Hepatology 68 1755-273
- [8] Heshmat R(2019)Age-related decrease in skeletal muscle mass is an independent risk factor for incident nonalcoholic fatty liver disease: a 10-year retrospective cohort study Gut Liver 13 67-1241
- [9] Roh E(2019)Sarcopenia: revised European consensus on definition and diagnosis Age Ageing 48 601-1130
- [10] Choi KM(2015)Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study Lancet 386 266-379